Lilly said it doesn't believe patients should be exposed to "the risks in taking untested, unapproved knockoffs." "FDA has rightly and repeatedly expressed concerns with unapproved GLP-1 drugs used for weight loss, and that such drugs are risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed," the company said in a statement to FOX Business
They also claim that drug manufacturers did not properly warn them about the risks associated with the medication
They should contact their prescriber or pharmacist for guidance and obtain a replacement if necessary
But I'm focused on a drug that I have to have in my life
Clinical trials demonstrate continued weight loss with dose escalation, and many patients benefit from titration to 10 mg or 15 mg weekly if tolerability permits
However, GI-related dehydration (from nausea/vomiting/diarrhea) can acutely worsen renal function